AU2021301444A1 - Quinazolinones derivatives for treatment of non-alcoholic fatty liver disease, preparation and use thereof - Google Patents
Quinazolinones derivatives for treatment of non-alcoholic fatty liver disease, preparation and use thereof Download PDFInfo
- Publication number
- AU2021301444A1 AU2021301444A1 AU2021301444A AU2021301444A AU2021301444A1 AU 2021301444 A1 AU2021301444 A1 AU 2021301444A1 AU 2021301444 A AU2021301444 A AU 2021301444A AU 2021301444 A AU2021301444 A AU 2021301444A AU 2021301444 A1 AU2021301444 A1 AU 2021301444A1
- Authority
- AU
- Australia
- Prior art keywords
- oxo
- dihydroquinazolin
- compound
- methoxyethyl
- urea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN202011027502A IN202011027502A (https=) | 2020-06-29 | 2020-06-29 | |
| IN202011027502 | 2020-06-29 | ||
| PCT/IN2021/050621 WO2022003712A1 (en) | 2020-06-29 | 2021-06-25 | Quinazolinones derivatives for treatment of non-alcoholic fatty liver disease, preparation and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2021301444A1 true AU2021301444A1 (en) | 2022-11-24 |
Family
ID=79315704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2021301444A Pending AU2021301444A1 (en) | 2020-06-29 | 2021-06-25 | Quinazolinones derivatives for treatment of non-alcoholic fatty liver disease, preparation and use thereof |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12528777B2 (https=) |
| EP (1) | EP4171569A4 (https=) |
| AU (1) | AU2021301444A1 (https=) |
| CA (1) | CA3182133A1 (https=) |
| IN (1) | IN202011027502A (https=) |
| WO (1) | WO2022003712A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4452952A4 (en) * | 2021-12-25 | 2025-12-03 | Council Of Scient And Industrial Research An Indian Registered Body Incorporated Under Regn Of Soc A | PREPARATION OF QUINAZOLINEDIONES AND THEIR USE |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1280874B (de) * | 1963-10-09 | 1968-10-24 | Boehringer Sohn Ingelheim | 2-Methyl-3-(2-dimethylaminophenyl)-8-amino-3H-chinazolon-(4) |
| US20080255161A1 (en) * | 2007-04-11 | 2008-10-16 | Dmitry Koltun | 3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS |
| CN101531638B (zh) * | 2008-03-13 | 2011-12-28 | 中国科学院广州生物医药与健康研究院 | 用作雌激素相关受体调节剂的化合物及其应用 |
| WO2010056230A1 (en) | 2008-10-15 | 2010-05-20 | Cv Therapeutics, Inc. | 3-hydroquinazolin-4-one derivatives for use as stearoyl coa desaturase inhibitors |
| SMT202000534T1 (it) * | 2015-12-09 | 2020-11-10 | Cadent Therapeutics Inc | Modulatori eteroaromatici del recettore nmda e loro usi |
| KR101932146B1 (ko) | 2016-07-14 | 2018-12-24 | 주식회사 바이오웨이 | Pi3k를 억제하는 신규한 퀴나졸리논 유도체 및 이를 포함하는 약학적 조성물 |
| EP4185380A4 (en) * | 2020-07-24 | 2024-08-21 | Inipharm, Inc. | Quinazolinone hsd17b13 inhibitors and uses thereof |
-
2020
- 2020-06-29 IN IN202011027502A patent/IN202011027502A/en unknown
-
2021
- 2021-06-25 US US18/013,681 patent/US12528777B2/en active Active
- 2021-06-25 WO PCT/IN2021/050621 patent/WO2022003712A1/en not_active Ceased
- 2021-06-25 CA CA3182133A patent/CA3182133A1/en active Pending
- 2021-06-25 AU AU2021301444A patent/AU2021301444A1/en active Pending
- 2021-06-25 EP EP21833670.9A patent/EP4171569A4/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IN202011027502A (https=) | 2021-12-31 |
| US12528777B2 (en) | 2026-01-20 |
| WO2022003712A1 (en) | 2022-01-06 |
| EP4171569A1 (en) | 2023-05-03 |
| EP4171569A4 (en) | 2024-07-03 |
| US20230357165A1 (en) | 2023-11-09 |
| CA3182133A1 (en) | 2022-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6861858B2 (ja) | Ｓｓａｏ阻害剤 | |
| JP7082446B2 (ja) | スルホキシイミングリコシダーゼ阻害剤 | |
| TWI676620B (zh) | 離胺酸特異性去甲基酶-１之抑制劑 | |
| TWI304061B (en) | Nitrogen-containing aromatic ring derivatives | |
| JP5820921B2 (ja) | １，２−二置換複素環式化合物 | |
| CN110452216B (zh) | 抗纤维化吡啶酮类 | |
| JP5828201B2 (ja) | ナフタレン誘導体 | |
| US9493440B2 (en) | Compounds inhibiting leucine-rich repeat kinase enzyme activity | |
| TW202214584A (zh) | Shp2抑制劑及其組合物和應用 | |
| JP2016518316A (ja) | Ｍｋ２阻害剤およびそれらの使用 | |
| GB2356197A (en) | Amide derivatives as beta 3 agonists | |
| US20100234419A1 (en) | Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators | |
| JP2001294586A (ja) | フルクトース−１，６−ビスホスファターゼ（ｆｂｐアーゼ）阻害物質としてのピペラジン類 | |
| WO2000021934A1 (en) | Compounds | |
| TW202448435A (zh) | 經取代之噻二唑基化合物 | |
| CN103189357B (zh) | 作为kcnq2/3调节剂的取代的2-氧代-和2-硫代-二氢喹啉-3-甲酰胺 | |
| JP2002529463A (ja) | 化合物 | |
| US12528777B2 (en) | Quinazolinones derivatives for treatment of non-alcoholic fatty liver disease, preparation and use thereof | |
| US20030105073A1 (en) | Quinolone derivatives | |
| AU2011297937B2 (en) | Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as KCNQ2/3 modulators | |
| WO2024182382A1 (en) | 4,5-fused bicyclic pyrrolidine and 4,5-fused bicyclic pyrrolidinone compounds | |
| TW202500133A (zh) | ３﹐４－稠合雙環吡咯啶及３﹐４－稠合雙環吡咯啶酮化合物 | |
| HK40016947B (en) | Anti-fibrotic pyridinones | |
| CN113015736A (zh) | 用于诱导软骨发生以治疗关节损害的6-羟基-8-氧杂三环[3.2.1.02,4]辛烷-2-甲酰胺衍生物 | |
| JPWO2001057044A1 (ja) | ピリドキサジン誘導体 |